considers more than forty variables across five categories: Corporate Taxes, Consumption Taxes, Property Taxes, Individual Taxes, and International Tax Rules.
HIGHER: Intra-Cellular (ITCI
), up 3% after announcing that it recently met with the FDA and reached agreement to submit additional non-clinical information in connection with the FDA's ongoing review of the company's new drug application, or NDA, for lumateperone for the treatment of schizophrenia...
Intra-Cellular Therapies Inc (Nasdaq: ITCI
) has initiated a rolling submission of its New Drug Application (NDA) with the US Food and Drug Administration (FDA) for lumateperone for the treatment of schizophrenia, the biopharmaceutical company revealed on Wednesday.
Long-term debt to assets divides long-term debt (DLTT) by the market value of assets [(DLTT+DLC) + PRCCF*CSHO + PSTKL - (TXDC + ITCI
, International Timber Company of Indonesia, was once a Weyerhauser timber concession; after the 1983 fires, the US-based company withdrew, leaving predominantly Indonesian military ownership.
) climbed 8.5% to close at $8.85 after the company announced it has reached an agreement to submit additional non-clinical information in connection with the FDA's ongoing review of the Company's New Drug application for lumateperone.
Shares of Intra-Cellular Therapies (ITCI
) dropped sharply and the stock was halted for volatility after the FDA cancelled an advisory committee meeting that had been planned to discuss an application made by the company.
E is earnings before extraordinary items (IB:18) plus interest expense (XINT:15), deferred tax credits (TXDI:50), and investment tax credits (ITCI
V East Kalimantan PT ITCI
East Kalimantan PT Kiani Lestari East Kalimantan PT ITCI
Many of the programs of the PT ITCI
(International Timber Corporation Indonesia) ignore the needs of the people and instead of improving sawah and irrigation, and taking good care of the natural resources of the forest (source of secondary income for the people), they have built village administrative buildings, a cooperative office, a small mosque, and sports facilities.
) gained 5.6% to $8.61 after the company announced it has reached an agreement to submit additional non-clinical information in connection with the FDA's ongoing review of the Company's New Drug application for lumateperone.
LOWER: Intra-Cellular (ITCI
), down 16% after Study 401 of lumateperone did not its meet primary endpoint...